Kopran Share Price

Kopran Share Price

NSE: KOPRAN
|
Pharmaceuticals
|
S Cap
₹ 199.71
+₹9.51 (5.00%)
1D
Last updated 17 Aug, 2026, 15:29 IST

Kopran Share Price Today

As of 18 Aug 2026, Kopran share price is ₹199.71. The stock opened at ₹196.99, compared to its previous close of ₹190.20. During today's trading session, Kopran share price moved in the range of ₹192.10 to ₹199.71, with an average price of ₹195.91 for the day. Looking at its last 52-week, the stock has touched a low of ₹107.00 and a high of ₹219.00. On the performance front, Kopran share price has increased by 50.63% over the last six months and is up 27.23% on a year-on-year basis.


₹192.10
5.00% up today
₹199.71
1D LOW
1D HIGH

Kopran Returns Calculator


Circuit
L
H
₹189.73
₹209.69
52-week
L
H
₹107.00
₹219.00

About Kopran

Kopran Share Price
ISIN
INE082A01010
Sector Market Cap
₹ 918.15 Cr

Kopran Limited is an India-based pharmaceutical company. The Company is primarily engaged in the business of manufacturing of formulation (finished dosage form) and active pharmaceutical ingredients (API). Its formulations product categories include penicillin-based finished oral dosage forms and non-penicillin-based finished oral dosage forms. The Company's penicillin-based finished oral dosage forms include amoxycillin, ampicillin, cloxacillin, amoxy clauv, flucloxacillin, and phenoxy methyl penicillin. Its non-penicillin-based finished oral dosage forms include macrolides, cardiovascular, anti-helmentics, antihistamine, anti-diabetic, pain management, gastroenterology, and respiratory. It has a portfolio, producing over 100 dosage forms. These include tablets, capsules, dry powder, suspension and injectables. Its subsidiary, Kopran Research Laboratories Ltd, manufactures a range of APIs, including Atenolol and Sterile Carbapenems.

Kopran Financial Highlights

  • Revenue: Kopran reported revenue of ₹681.77 crore in FY26 vs ₹633.58 crore in FY25. It showed an increase of 7.61% on a yearly basis.
  • Operating Profit: Kopran reported an operating profit of ₹34.36 crore in FY26 vs ₹51.95 crore in FY25. It showed a decrease of 33.86% on a year-on-year basis.
  • Net Profit: Kopran reported a net profit of ₹25.73 crore in FY26 vs ₹38.55 crore in FY25. It showed a decrease of 33.26% on a yearly basis.

Kopran Quarterly Result Highlights

  • Kopran reported revenue of ₹156.04 crore in Jun 2026, compared with ₹234.11 crore in Mar 2026, representing a decrease of 33.35% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported an operating profit of ₹8.80 crore in Jun 2026, compared with ₹25.35 crore in Mar 2026, representing a decrease of 65.29% on a quarter-on-quarter (QoQ) basis.
  • Kopran reported a profit of ₹6.70 crore in Jun 2026, compared with ₹18.87 crore in Mar 2026, reflecting a decrease of 64.49% on a QoQ basis.
  • The earnings per share (EPS) of Kopran stood at ₹5.33 during Jun 2026.
Know more
Promoters
44.42%
FII
0.51%
Other DII
0.00%
Retail and other
55.06%
Mutual funds
0.00%
Foreign institutions - FII
FII shareholding by period
Sep 20250.60%
Dec 20250.36%
Mar 20260.57%
Jun 20260.51%
Mkt Cap Cr
918.15

P/E
36.78

P/B
1.73

ROE
4.85%

D/E
0.10

ROCE
6.56%

Div. Yield
1.58%

EPS(TTM)
6.30
Turnover
0.52

EV/EBITDA
16.76

Net Margin
9.95%

Op. Margin
16.22%

ROA
2.75%

Quick Ratio
1.19

Curr. Ratio
2.32
Based on fundamentals, this stock's
Step 1 of 5
Performance
Very Poor
Kopran has not beaten FD return of 7%
Step 1 of 5
Valuation
Overvalued
Kopran appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Kopran earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,61,848.0038.125.5313.74%0.6117.33%93.240.83%0.4810.90
Divis Laboratories2,25,648.0077.1513.4615.32%0.0019.56%629.490.35%0.5598.19
Torrent Pharmaceuticals1,86,190.0085.4021.8925.49%1.6913.85%222.760.70%0.4958.70
Cipla1,15,523.0034.913.4011.27%0.0014.95%423.360.90%0.4543.52
Zydus Lifesciences1,13,715.0024.764.1918.59%0.3117.35%237.300.09%0.3335.38
Lupin1,03,298.0018.614.6023.76%0.0424.88%659.050.81%0.57129.18
Dr. Reddy's Laboratories1,00,328.0031.252.6111.07%0.1812.54%377.960.67%0.4138.68
Mankind Pharma99,117.0048.346.1311.74%0.3413.13%397.020.04%0.4449.37
Laurus Labs97,202.2089.9418.5016.77%0.4016.14%97.200.11%0.6713.72
Aurobindo Pharma96,296.9025.952.549.25%0.1911.76%391.140.25%0.3841.58

Kopran Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹681.42₹629.60₹614.59₹550.99
Other Income₹0.35₹3.98₹14.61₹3.07
Total Revenue₹681.77₹633.59₹629.20₹554.05
Total Expenses₹647.41₹581.64₹561.66₹517.99
Profit Before Tax₹34.36₹51.95₹67.54₹36.07
Tax₹8.63₹13.40₹16.59₹8.83
Profit After Tax₹25.73₹38.55₹50.96₹27.23
EPS - Basic₹5.33₹7.99₹10.57₹5.65
EPS - Diluted₹5.33₹7.99₹10.57₹5.65

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹51.95₹67.54₹36.07₹81.78
Income before WC changes₹76.75₹88.50₹52.36₹95.60
Change in Assets-₹39.13-₹37.47-₹73.13-₹89.48
Change in Liabilities₹17.57₹6.55₹67.58-₹21.33
Change in WC-₹21.56-₹30.91-₹5.55-₹110.81
Cash flow from Operations₹41.94₹43.26₹34.02-₹33.48
Cash flow from Investing-₹56.43-₹43.55-₹12.65-₹84.42
Cash flow from Financing₹25.87₹0.99-₹19.84₹122.82
Total Cash Flow₹11.38₹0.69₹1.53₹4.93
Cash (Start of the year)₹8.09₹7.40₹5.87₹0.94
Cash (End of the year)₹19.47₹8.09₹7.40₹5.87

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹385.19₹334.26₹289.22₹250.63
Current Assets₹523.18₹509.75₹454.03₹399.07
Total Assets₹908.36₹844.01₹743.25₹649.70
Current Liabilities₹346.18₹288.97₹218.53₹176.97
Net Current Asset₹177.00₹220.78₹235.50₹222.10
Non-Current Liabilities₹31.90₹36.70₹33.47₹33.48
Equity Capital₹530.28₹518.35₹491.25₹439.25
Total Equity & Liabilities₹908.36₹844.01₹743.25₹649.70

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹305.65₹271.01₹337.46₹273.09
Other Income₹2.00₹5.90₹16.71₹16.09
Total Revenue₹307.65₹276.91₹354.17₹289.18
Total Expenses₹267.25₹241.12₹309.65₹252.27
Profit Before Tax₹40.39₹35.79₹44.52₹36.92
Tax₹9.99₹8.94₹9.88₹5.66
Profit After Tax₹30.40₹26.86₹34.64₹31.25
EPS - Basic₹6.30₹5.57₹7.18₹6.48
EPS - Diluted₹6.30₹5.57₹7.17₹6.48

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax₹35.79₹44.52₹36.92₹16.16
Income before WC changes₹42.38₹47.20₹27.87₹20.33
Change in Assets-₹5.26₹8.36-₹39.24-₹41.63
Change in Liabilities-₹3.73-₹10.77₹34.55-₹12.90
Change in WC-₹8.99-₹2.41-₹4.68-₹54.53
Cash flow from Operations₹23.30₹34.96₹16.87-₹37.80
Cash flow from Investing-₹15.41-₹6.27₹10.05-₹100.26
Cash flow from Financing₹5.64-₹24.08-₹26.13₹137.99
Total Cash Flow₹13.53₹4.61₹0.79-₹0.07
Cash (Start of the year)₹5.65₹1.04₹0.25₹0.32
Cash (End of the year)₹19.18₹5.65₹1.04₹0.25

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹365.65₹337.44₹323.17₹315.54
Current Assets₹240.24₹209.05₹187.70₹190.41
Total Assets₹605.89₹546.48₹510.88₹505.95
Current Liabilities₹146.94₹103.33₹84.54₹100.88
Net Current Asset₹93.29₹105.72₹103.16₹89.53
Non-Current Liabilities₹11.12₹11.72₹9.47₹9.48
Equity Capital₹447.83₹431.44₹416.87₹395.59
Total Equity & Liabilities₹605.89₹546.48₹510.88₹505.95
* All values are in INR Crore
Qty
Bid
49750
199.71
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 49750
Ask Total: 0
Buy orders: 100%
Sell orders: 0%
Bearish
4
Neutral
3
Bullish
1
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict

RSI (14)
58.1
Neutral

ATR (14)
9.77
Neutral

STOCH(9,6)
100
Bearish

STOCH RSI (14)
100
Bearish

ADX(9)
37.57
Bearish

UO(9)
64.94
Neutral

ROC(12)
6.19
Bullish

WillR(14)
-5.31
Bearish
Period
Simple value
Exponential vaue

5D
183.59
188.54

10D
185.25
187.25

20D
190.8
189.07

50D
191.23
187.3

100D
174.27
176.74
Volume trend — traded volume by day
17 Aug1L
14 Aug1L
13 Aug1L
12 Aug0L
11 Aug1L
Average1L
Compare against other stocks
Kopran Share Price
Kopran
Pharmaceuticals
Add Stock
Add Another

Kopran Share Price FAQs